Insulin-Like Growth Factor 1 (IGF-1), also known as Mecasermin, is a pharmaceutical-grade recombinant human growth factor used for the treatment of severe primary IGF-1 deficiency and growth failure in pediatric patients. IGF-1 is a naturally occurring peptide hormone that mediates many of the biological effects of growth hormone, promoting normal growth, tissue repair, cellular proliferation, and protein synthesis.
Recombinant IGF-1 binds to the IGF-1 receptor, stimulating cell growth, skeletal development, and metabolic regulation. It is administered as a subcutaneous injectable formulation for patients with confirmed IGF-1 deficiency.
Manufactured under WHO-GMP-certified biopharmaceutical facilities, our IGF-1 API is produced using advanced recombinant DNA technology to ensure exceptional purity, biological activity, stability, and batch-to-batch consistency. Every batch undergoes rigorous analytical testing and is supplied with Certificate of Analysis (CoA), Material Safety Data Sheet (MSDS), Technical Data Sheet (TDS), and complete regulatory documentation.
IGF-1 API is used in injectable biopharmaceutical formulations for the treatment of severe primary IGF-1 deficiency and pediatric growth disorders.
IGF-1 binds to the insulin-like growth factor receptor, stimulating cell growth, protein synthesis, tissue development, and normal skeletal growth.
Yes. We provide CoA, MSDS, Technical Data Sheet (TDS), Product Specifications, and complete regulatory documentation with every shipment.
Yes. We supply Insulin-Like Growth Factor 1 (IGF-1) API in commercial quantities for pharmaceutical and biopharmaceutical manufacturing worldwide.
Get Bulk Quote via WhatsApp